The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multi-center randomized study of pembrolizumab/carboplatin versus carboplatin alone in patients with chest wall disease from breast cancer: TBCRC 044.
 
Neelima Vidula
Consulting or Advisory Role - Abbvie
Research Funding - Daehwa Pharmaceutical (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Rita Nanda
Consulting or Advisory Role - Aduro Biotech; Athenex; Daiichi Sankyo; Genentech/Roche; Immunomedics; ION Pharma; Macrogenics; Merck; Pfizer; Seagen
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Celgene (Inst); Corcept Therapeutics (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Merck (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Seagen (Inst)
Other Relationship - G1 Therapeutics
 
Kathy D. Miller
No Relationships to Disclose
 
Leisha A. Emens
Leadership - Society for Immunotherapy of Cancer; Society for Immunotherapy of Cancer
Stock and Other Ownership Interests - Molecuvax
Consulting or Advisory Role - Abbvie; Bayer; Bristol Meyers Squibb; Chugai Pharma; CytomX Therapeutics; etheRNA; Genentech/Roche; Gilead Sciences; GPCR Therapeutics; Gritstone Bio; Lilly; Macrogenics; Medimmune; Molecuvax; Novartis; Peregrine Pharmaceuticals; Replimune; Shionogi; Silverback Therapeutics; Syndax
Research Funding - Aduro Biotech; AstraZeneca; Bolt Biotherapeutics; Bristol Myers Squibb; Corvus Pharmaceuticals; EMD Serono; Genentech; Maxcyte; Merck; Roche; Silverback Therapeutics; Takeda; Tempest Therapeutics
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech; Roche
Other Relationship - Aduro Biotech
 
Paula R Pohlmann
Leadership - Immunonet BioSciences
Stock and Other Ownership Interests - Immunonet BioSciences
Honoraria - Dava Oncology; Frontiers Media; OncLive/MJH Life Sciences
Consulting or Advisory Role - Bolt Biotherapeutics; Caris Life Sciences; HERON; Immunonet BioSciences; Juniper Pharmaceuticals; OncoPlex Diagnostics; Personalized Cancer Therapy; Pfizer; Puma Biotechnology; Sirtex Medical
Speakers' Bureau - Genentech/Roche
Research Funding - Advanced Cancer Therapeutics (Inst); Bolt Biotherapeutics (Inst); Byondis (Inst); Caris Centers of Excellence (Inst); Caris Centers of Excellence (Inst); Cascadian Therapeutics (Inst); Fabre-Kramer (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Pfizer (Inst); Pfizer (Inst); Pieris Pharmaceuticals (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Patent application; United States Patent no. 8,486,413.; United States Patent no. 8,501,417; United States Patent no. 9,023,362; United States Patent no. 9,745,377
 
Vandana G Abramson
Employment - HCA Healthcare (I)
Consulting or Advisory Role - Abbvie; Daiichi Sankyo; Eisai
Research Funding - Genentech/Roche; Lilly
 
Ben Ho Park
Leadership - Loxo
Stock and Other Ownership Interests - Celcuity; Loxo
Honoraria - AstraZeneca
Consulting or Advisory Role - Casdin Capital; Celcuity; Foundation Medicine; H3 Biomedicine; Horizon Discovery; Jackson Laboratory for Genomic Medicine; Lilly; Loxo; Pathovax; Sermonix Pharmaceuticals
Research Funding - Abbvie; GE Healthcare; Lilly; Pfizer
Patents, Royalties, Other Intellectual Property - Royalties paid through inventions at Johns Hopkins University by Horizon Discovery LTD
Travel, Accommodations, Expenses - Lilly; Loxo
(OPTIONAL) Uncompensated Relationships - Tempus
 
Minetta C. Liu
Research Funding - Eisai (Inst); Genomic Health (Inst); GRAIL (Inst); Menarini Silicon Biosystems (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Seagen (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); Genomic Health; GRAIL; Ionis Pharmaceuticals (Inst); Menarini Silicon Biosystems; Merck; Pfizer
 
Andrei Goga
No Relationships to Disclose
 
Hope S. Rugo
Honoraria - Mylan; Puma Biotechnology
Consulting or Advisory Role - Samsung
Research Funding - AstraZeneca (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Genentech (Inst); Immunomedics (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Daiichi Sankyo; Macrogenics; Merck; Mylan; Novartis; Pfizer